P3 Health Partners (NASDAQ:PIII) Price Target Cut to $4.50

P3 Health Partners (NASDAQ:PIII) had its price target dropped by analysts at Lake Street Capital from $9.00 to $4.50 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Lake Street Capital’s price objective would suggest a potential upside of 365.45% from the stock’s current price.

P3 Health Partners Stock Down 5.2 %

Shares of P3 Health Partners stock traded down $0.05 during trading on Thursday, reaching $0.97. The company’s stock had a trading volume of 384,323 shares, compared to its average volume of 406,463. The company has a market cap of $302.70 million, a price-to-earnings ratio of 0.00 and a beta of 1.05. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The company has a 50-day simple moving average of $1.11 and a two-hundred day simple moving average of $1.35. P3 Health Partners has a 1-year low of $0.66 and a 1-year high of $5.56.

Hedge Funds Weigh In On P3 Health Partners

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. GSA Capital Partners LLP raised its stake in P3 Health Partners by 170.1% in the 4th quarter. GSA Capital Partners LLP now owns 268,586 shares of the company’s stock worth $379,000 after acquiring an additional 169,140 shares during the last quarter. Barclays PLC raised its stake in shares of P3 Health Partners by 680.2% during the 4th quarter. Barclays PLC now owns 56,134 shares of the company’s stock valued at $79,000 after buying an additional 48,939 shares during the last quarter. Nuveen Asset Management LLC raised its stake in shares of P3 Health Partners by 8.9% during the 4th quarter. Nuveen Asset Management LLC now owns 171,070 shares of the company’s stock valued at $241,000 after buying an additional 14,018 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of P3 Health Partners during the 4th quarter valued at about $25,000. Finally, Welch Capital Partners LLC NY purchased a new position in shares of P3 Health Partners during the 4th quarter valued at about $42,000. Hedge funds and other institutional investors own 23.57% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.